Tumor necrosis factor-α gene G-308A polymorphism is a risk factor for the development of membranous glomerulonephritis

American Journal of Nephrology

Volumn 26, Issue 1, 2006, Pages 12-15

  Bantis, Christos ^a   Heering, Peter J ^a   Aker, Sendogan ^a   Siekierka, Magdalena ^a   Kuhr, Nicola ^a   Grabensee, Bernd ^a   Ivens, Katrin ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

G 308A polymorphism; Genetic polymorphism; Membranous glomerulonephritis; Tumor necrosis factor

Indexed keywords

CREATININE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; INCIDENCE; KAPLAN MEIER METHOD; KIDNEY BIOPSY; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR;

ADULT; ALLELES; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; MALE; POLYMORPHISM, GENETIC; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33645680040     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090706     Document Type: Article

References (19)

1. Wilson AG, di Giovine FS, Blakemore AI, Duff GW: Single base polymorphism in the human tumour necrosis factor-α gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992;1:353.
2. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW: Effects of a polymorphism in the human tumor necrosis factor-α promoter on transcriptional activation. Proc Natl Acad Sci USA 1997;94:3195-3199.
3. Kroeger KM, Carville KS, Abraham LJ: The -308 tumor necrosis factor-α promoter polymorphism effects transcription. Mol Immunol 1997;34:391-399.
4. Bouma G, Crusius JB, Oudkerk Pool M, Kolkman JJ, von Blomberg BM, Kostense PJ, Giphart MJ, Schreuder GM, Meuwissen SG, Pena AS: Secretion of tumour necrosis factor-α and lymphotoxin-α in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol 1996;43:456-463.
5. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993;329:1456-1462.
6. Baud L, Oudinet JP, Bens M, Noe L, Peraldi MN, Rondeau E, Etienne J, Ardaillou R: Production of tumor necrosis factor by rat mesangial cells in response to bacterial lipopolysaccharide. Kidney Int 1989;35:1111-1118.
7. Bertani T, Abbate M, Zoja C, Corna D, Perico N, Ghezzi P, Remuzzi G: Tumor necrosis factor induces glomerular damage in the rabbit. Am J Pathol 1989;134:419-430.
8. Hruby ZW, Shirota K, Jothy S, Lowry RP: Antiserum against tumor necrosis factor-α and a protease inhibitor reduce immune glomerular injury. Kidney Int 1991;40:43-51.
9. Suranyi MG, Guasch A, Hall B, Myers B: Elevated levels of tumor necrosis factor-α in the nephrotic syndrome in humans. Am J Kidney Dis 1993;21:251-259.
10. Honkanen E, Teppo AM, Meri S, Lehto T, Gronhagen-Riska C: Urinary excretion of cytokines and complement SC5b-9 in idiopathic membranous glomerulonephritis. Nephrol Dial Transplant 1994;9:1553-1559.
11. Honkanen E, von Willebrand E, Teppo AM, Tornroth T, Gronhagen-Riska C: Adhesion molecules and urinary tumor necrosis factor-α in idiopathic membranous glomerulonephritis. Kidney Int 1998;53:909-917.
12. Matsumoto K: Increased release of tumor necrois factor-α by monocytes from patients with glomerulonephritis. Clin Nephrol 1993;40:148-154.
13. Neale TJ, Ruger BM, Macaulay H, Dunbar PR, Hasan Q, Bourke A, Murray-McIntosh RP, Kitching AR: Tumor necrosis factor-α is expressed by glomerular visceral epithelial cells in human membranous nephropathy. Am J Pathol 1995;146:1444-1454.
14. Mulligan MS, Johnson KJ, Todd RF 3rd, Issekutz TB, Miyasaka M, Tamatani T, Smith CW, Anderson DC, Ward PA: Requirements for leukocyte adhesion molecules in nephrotoxic nephritis. J Clin Invest 1993;91:577-587.
15. Booth A, Harper L, Hammad T, Bacon P, Griffith M, Levy J, Savage C, Pusey C, Jayne D: Prospective study of TNF-α blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis. J Am Soc Nephrol 2004;15:717-721.
16. Danis VA, Millington M, Hyland V, Lawford R, Huang Q, Grennan D: Increased frequency of the uncommon allele of a tumour necrosis factor-α gene polymorphism in rheumatoid arthritis and systemic lupus erythematosus. Dis Markers 1995;12:127-133.
17. Sankaran D, Asderakis A, Ashraf S, Roberts IS, Short CD, Dyer PA, Sinnott PJ, Hutchinson IV: Cytokine gene polymorphisms predict acute graft rejection following renal transplantation. Kidney Int 1999;56:281-288.
18. Tuglular S, Berthoux P, Berthoux F: Polymorphisms of the tumour necrosis factor-α gene at position -308 and TNFd microsatellite in primary IgA nephropathy. Nephrol Dial Transplant 2003;18:724-731.
19. Bantis C, Heering P, Luther Y, Aker S, Klein-Vehne N, Grabensee B, Ivens K: Influence of cytokine gene polymorphisms on focal segmentai glomerulosclerosis. Am J Nephrol 2004;24:427-431.